The incidence of oral herpes simplex virus infection in patients undergoing cancer chemotherapy
- 1 March 1986
- journal article
- research article
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology
- Vol. 61 (3) , 238-242
- https://doi.org/10.1016/0030-4220(86)90368-3
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial.BMJ, 1983
- Oral acyclovir prophylactic treatment of herpes simplex infection after bone marrow transplantationJournal of Antimicrobial Chemotherapy, 1983
- Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patientsJournal of Antimicrobial Chemotherapy, 1983
- Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised hostThe American Journal of Medicine, 1982
- Oral infections associated with chemotherapy in adults with acute leukemiaPostgraduate Medicine, 1982
- Intravenous Acyclovir to Treat Mucocutaneous Herpes Simplex Virus Infection After Marrow TransplantationAnnals of Internal Medicine, 1982
- Acyclovir Prophylaxis of Herpes-Simplex-Virus InfectionsNew England Journal of Medicine, 1981
- Chemotherapy-induced oral mucositis in adult leukemiaPostgraduate Medicine, 1981
- Infection with Herpes Simplex Virus and Cell-Mediated Immunity after Marrow TransplantThe Journal of Infectious Diseases, 1980
- Oral complications of bone marrow transplantationPostgraduate Medicine, 1979